Genesis Therapeutics
Oct 20, 2020
Venclexta full approval; PBP1510 Orphan Status; Roche/ Genesis collab; Immunomodulators for COVID-19
Full FDA Approval for Venclexta Combinations for Acute Myeloid Leukemia The US FDA has granted its full approval to Venclexta (venetoclax) for newly diagnosed acute myeloid leukemia (AML) in adults 75 years or older who are unfit for intensive induction chemotherapies. The approval is based on the res...
Read More...
-Agonist.png "Toll-like Receptors Agonist")
